SCHEMBL1918464

SCHEMBL1918464

CCOC(=O)C(CC)C1(C(=O)O)CCCC1=O

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 9/20 0.46
▸ CYP3A4 P08684 6/20 0.46
▸ TSHR P16473 4/20 0.42
▸ CYP2C9 P11712 4/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ KMT2A Q03164 3/20 0.39
▸ CYP2D6 P10635 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ MAPT P10636 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9168187 0.76 CYP2C19 (0.43) CYP2C19CYP3A4TSHRCYP2C9ALDH1A1
SCHEMBL11294014 0.74 CYP2C19 (0.55) CYP2C19CYP3A4TSHRCYP2C9ALDH1A1
SCHEMBL6061194 0.72 CYP2C19 (0.37) CYP2C19CYP3A4TSHRCYP2C9ALDH1A1
SCHEMBL4812312 0.68 CYP2C19 (0.43) CYP2C19CYP3A4TSHRCYP2C9ALDH1A1
SCHEMBL27794018 0.68 CYP2C19 (0.67) CYP2C19CYP3A4TSHRCYP2C9ALDH1A1
SCHEMBL28255942 0.67 CYP2C19 (0.45) CYP2C19CYP3A4TSHRCYP2C9ALDH1A1
SCHEMBL28544353 0.67 CYP2C19 (0.42) CYP2C19CYP3A4TSHRCYP2C9ALDH1A1
SCHEMBL8829500 0.67 GRIK1 (0.35) CYP2C19CYP3A4TSHRCYP2C9MAPT
SCHEMBL10817859 0.65 CYP2C19 (0.46) CYP2C19CYP3A4TSHRCYP2C9ALDH1A1
SCHEMBL11023831 0.65 CYP2C19 (0.35) CYP2C19CYP3A4TSHRCYP2C9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2528894-A1 PROCESSES FOR THE PREPARATION OF (R)-2-(7-(4-CYCLOPENTYL-3-(TRIFLUOROMETHYL)BENZYLOXY)-1,2,3,4-TETRAHYDROCYCLOPENTA[B]INDOL-3-YL)ACETIC ACID AND SALTS THEREOF Arena Pharmaceuticals, Inc. (US) 2012-12-05 — — EP disclosed
WO-2011094008-A1 PROCESSES FOR THE PREPARATION OF (R)-2-(7-(4-CYCLOPENTYL-3-(TRIFLUOROMETHYL)BENZYLOXY)-1,2,3,4-TETRAHYDROCYCLOPENTA[B]INDOL-3-YL)ACETIC ACID AND SALTS THEREOF ARENA PHARMACEUTICALS, INC. (US) 2011-08-04 — — WO disclosed
EP-2326621-A1 SUBSTITUTED 1,2,3,4- TETRAHYDROCYCLOPENTA[b]INDOL-3-YL) ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS Arena Pharmaceuticals, Inc. (US) 2011-06-01 — — EP disclosed
EP-2222668-A1 TETRAHYDROCYCLOPENTA[B]INDOL-3-YL CARBOXYLIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS Arena Pharmaceuticals, Inc. (US) 2010-09-01 — — EP disclosed
WO-2010011316-A1 SUBSTITUTED 1,2,3,4- TETRAHYDROCYCLOPENTA[b]INDOL-3-YL) ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS ARENA PHARMACEUTICALS, INC. (US) 2010-01-28 — — WO disclosed
WO-2009078983-A1 TETRAHYDROCYCLOPENTA[B]INDOL-3-YL CARBOXYLIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS ARENA PHARMACEUTICALS, INC. (US) 2009-06-25 — — WO disclosed
Send feedback